Orientation To Children & Youth With Autism Spectrum Disorders
Outline
I.
Characteristics of ASD
A. Impairments
in social skills
B. Impairments
in verbal and nonverbal communication
C. Restricted
& repetitive interests or behaviors
II.
Diagnostic criteria
A. Autism
Disorder
B. Asperger’s
Disorder
C. PDD-NOS
D. Rett’s
Syndrome
E. Childhood
Disintegrative D/O
III.
Etiology & prevalence
A. CDC:
1 in 166 (1500% rate of increase) (4/10,000 to 60/10,000)
B. 4:1
ratio boys to girls
C. Girls
– more cognitive impairment
D. Genetic
vulnerability, environmental triggers, & timing of exposure
E. Multiple
neurological & developmental pathways
F. Neurobiological
features
IV.
Co-morbid conditions
A. Seizures
B. Sleep
problems
C. Gastro-intestinal
problems
D. Allergy/immune
disorders
E. Metabolic
disorders
F. Hormonal
imbalance
G. Sensory-motor
challenges
H. Hyperactivity
and attentional abnormalities
I.
Mental health/mood disorders
J. Mental
retardation
K. Fragile
X
L. Tuberous
sclerosis
V.
Characteristics of best practice
A. Early
and intensive
B. Multidisciplinary
assessment & treatment
C. Naturalistic
environments
D. Strength-based
E. Focus
on remediation of core deficits specific to ASD
F. Data-based
decision-making
G. Family
involvement & attitude
VI.
Assessment
A. Diagnostic
assessment instruments
B. Cognitive
/ developmental
C. Mental
status / stress
D. Sensory-motor
Assessment
E. Medical
evaluations
VII.
Behavioral treatment models that address core deficit
areas
A. Social
development interventions
B. Language/communication-based
interventions
C. Sensory
and motor interventions
D. Challenging
behavior interventions
E. General
skill building and educational strategies
F. Psychotherapies
VIII.
Biomedical treatment models that address associated
physical conditions
A. Psychopharmocology
1. Neuroleptics/Antipsychotics
2. Risperidone
3. Clomipramine
4. Selective
Serontonin Reuptake Inhibitors (SSRIs)
5. Antidepressants
6. Stimulants
7. Anticonvulsants
B. Biomedical
treatment options with minimal evidence of effectiveness /potential risk
1. Secretin
2. Gluten-free,
Casien-free diet
3. Enzymes,
vitamin, & mineral supplements
4. Chelation
therapy
IX.
Family-based Interventions
A. Counseling,
family therapy, support groups
B. Parent
training
C. Case
management; systems navigation
D. Respite
E. Supports
for siblings
In-home and placement services
Presented by Susan E. Stevenson,
Director, ASD & Care Coordination Services
Date: Thursday, February 12, 2009
Time: 10:00am-12:00pm
Location: TBA
3 CEU's will be offered
This presentation is open to all but space is limited. Please contact Naomi Ingersoll at 848-4109 or email ningersoll@childandfamilyri.com to register.